BNR
Burning Rock Biotech Ltd.
NASDAQ · Healthcare · Medical - Diagnostics & Research · CN
$14.71
+8.80%Margins
Gross margin
74.6%
EBITDA margin
-8.4%
EBIT margin
-13.0%
Net margin
-13.6%
FCF margin
-3.5%
-13.7%
Return on equity
-9.1%
Return on assets
-12.0%
Return on invested capital
0.65x
Asset turnover
-$1.8M
Cash from operations
$5.92
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026